TGFB1 and systemic sclerosis: Taken together, these observations suggest that fibrotic disease progression in SSc may be driven by distinct mechanisms in lung and skin, where IL6 and fibrosis-associated macrophages are more closely associated with lung function while other targets such as TGFβ and myofibroblasts may be more closely associated with skin fibrosis.